PRISM BioLab Co.,LTD FY2025 FY Earnings Report | IR Tracker

PRISM BioLab Co.,LTD FY2025 FY Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥677M
Operating Income: ¥-774M
Net Income: ¥-833M
EPS: ¥-22.82

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥677M	¥305M	+122.0%
Cost of Sales	¥408M	¥145M	+180.9%
Gross Profit	¥270M	¥161M	+68.0%
SG&A Expenses	¥1.04B	¥943M	+10.7%
Operating Income	¥-774M	¥-782M	+1.0%
Non-operating Income	¥27M	¥788,000	+3304.2%
Non-operating Expenses	¥674,000	¥50M	-98.6%
Ordinary Income	¥-748M	¥-831M	+10.0%
Profit Before Tax	¥-831M	¥-1.05B	+20.7%
Income Tax Expense	¥2M	¥1M	+84.7%
Net Income	¥-833M	¥-1.05B	+20.6%
Basic EPS	¥-22.82	¥-33.53	+31.9%
Dividend Per Share	¥0.00	¥0.00	-

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥3.04B	¥4.48B	¥-1.44B
Cash and Deposits	¥2.92B	¥4.39B	¥-1.48B
Non-current Assets	¥47M	¥45M	+¥1M
Property, Plant & Equipment	¥0	¥0	¥0
Total Assets	¥3.08B	¥4.53B	¥-1.44B

Cash Flow Statement

Item	Current	Prior	Change
Operating Cash Flow	¥-1.47B	¥150M	¥-1.62B
Investing Cash Flow	¥-69M	¥-244M	+¥175M
Financing Cash Flow	¥33M	¥3.37B	¥-3.34B
Free Cash Flow	¥-1.54B	-	-

Profitability Ratios

Item	Value
Operating Margin	-1.1%
ROA (Ordinary Income)	-19.7%
Book Value Per Share	¥73.40
Net Profit Margin	-123.0%
Gross Profit Margin	39.8%
Current Ratio	821.1%
Quick Ratio	821.1%
Debt-to-Equity Ratio	0.14x
Effective Tax Rate	-0.3%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	+121.6%

Item	Value
Shares Outstanding (incl. Treasury)	36.81M shares
Average Shares Outstanding	36.53M shares
Book Value Per Share	¥73.57

Dividend Information

Item	Amount
Q2 Dividend	¥0.00
Year-End Dividend	¥0.00

Full Year Forecast

Item	Forecast
Dividend Per Share Forecast	¥0.00